
IGES Institute with a new branch in Nuremberg
01.03.2012 17:18
The IGES Institute is expanding its nationwide presence and expanding its range of services for the evaluation of new therapies. In addition to its headquarters in Berlin, the country's largest private-sector and independent research institute of its kind for the healthcare sector will have an office in Nuremberg. There, experts in the field of Health Economics & Outcomes Research (HEOR) will conduct research and advice. The team is led by physician Wioletta Kotowa, who specializes in health economics issues.
“Benefit assessments and health economic analyzes have always been among the core competencies of the IGES Institute. We are strengthening this in order to meet the increased demand in this area, which is particularly brought about by the Pharmaceutical Market Reorganization Act, the AMNOG,” says Professor Dr. Bertram Häussler, Chairman of the Management Board of the IGES Institute.
The Nuremberg IGES team brings together doctors, pharmacists and economists and, according to the institute, works closely with its Berlin colleagues, especially in the areas of statistics, biometrics, health services research and the pharmaceutical market. It specializes in cost-effectiveness analyses, benefit analyses, cost of illness studies and the quantification of patient-relevant benefits. One focus of activity should be the creation of dossiers for benefit assessment by the Federal Joint Committee (G-BA).
